Recombinant PCSK9 (Ebronucimab Biosimilar) antibody
The Human Monoclonal anti-PCSK9 (Ebronucimab Biosimilar) antibody (ABIN7675946) specifically detects PCSK9 (Ebronucimab Biosimilar) in BLI, ELISA, FACS, Func and SPR.
The antibody is reactive with Human samples.
Catalog No. ABIN7675946
$346.15
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 12 Business Days
Quick Overview for Recombinant PCSK9 (Ebronucimab Biosimilar) antibody (ABIN7675946)
Target
PCSK9 (Ebronucimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-PCSK9 Reference Antibody (ebronucimab)
-
Characteristics
- Anti-PCSK9 Reference Antibody (ebronucimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- PCSK9 (Ebronucimab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- Q8NBP7
Target
-
You are here:
